8don MSN
Rakhi Sawant Opens Up About Not Being Able To Become A Mother: Agar Khuda Ne Chaha... - EXCLUSIVE
Rakhi Sawant, in an exclusive chat with Zoom, revealed she underwent emergency surgery for a large uterine cyst. Told she can ...
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) accepted for priority review a supplemental Biologics Li ...
US Weekly on MSN
Kirsten Storms Reveals She Has to Undergo Surgery for a Brain Aneurysm Amid ‘General Hospital’ Break
Kirsten Storms is preparing for another brain surgery after doctors found an aneurysm four years after her last procedure. The General Hospital actress, who is currently on leave from the soap opera, ...
The couple, who have a three-year-old daughter named Athena, went to hospital where it was found Assem had a ruptured dermoid ...
General Hospital star Kirsten Storms will undergo brain surgery for an aneurysm. The television star took to Instagram on October 14 to give her followers an update on her health after she had a cyst ...
News Medical on MSN
Rare Vulvar Cyst Report Highlights Diagnostic Hurdles
This case emphasizes the importance of considering rare vulvar mucinous cysts in the differential diagnosis of asymptomatic vulvar masses."BUFFALO ...
Soap Opera Digest on MSN
General Hospital’s Kirsten Storms (Maxie) Reveals New Health Battle, Will Undergo Brain Surgery
General Hospital star Kirsten Storms opened up about the health issues that played a role in her break from playing Maxie and her upcoming surgery.
2don MSN
Lawrence County man battles breast cancer, completes half-marathon, and founds support organization
"You can decide to go in a hole or hide, or you can make a decision to make a difference," Brian Chrobak, who is battling stage 4 male breast cancer, said.
US FDA grants priority review for Keytruda & Keytruda Qlex, each in combination with Padcev, for certain patients with muscle-invasive bladder cancer: Rahway, New Jersey Friday, O ...
Muscle-invasive bladder cancer patients who are ineligible or refuse cisplatin chemotherapy see “dramatic” improvements in survival outcomes with enfortumab vedotin plus pembrolizumab.
"Once damaged, these hairs never grow back. You have around 3,500, and that is all you'll have throughout your entire life...
FDA prioritizes review of enfortumab vedotin and pembrolizumab for muscle-invasive bladder cancer, showing promising results in reducing recurrence and mortality.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results